secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2023-02-02T23:59:59+00:00
Accession:  0000721371-23-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q2 revenue $51.5B, non-GAAP EPS $1.32; raises FY23 guidance
---------------------------------------------------------------------------

- Revenue $51.5B, up 13% YoY; GAAP operating loss $119M on $709M goodwill impairment in Medical segment.
- Non-GAAP diluted EPS $1.32, up 4% YoY; non-GAAP operating earnings $467M, flat YoY.
- Pharmaceutical segment profit $464M (+9%); Medical segment profit $17M (-66%).
- FY23 non-GAAP EPS guidance raised to $5.20-$5.50 from $5.05-$5.40; pharma profit growth outlook raised to 4-6.5%.
- Interest and other lowered to $115M-$130M from $140M-$160M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/0000721371-23-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/cah-20230202.htm
  HTML page:      https://secwatch.observer/filing/0000721371-23-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer